Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis.

MLA

Pizzamiglio, Sara, et al. “Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 23, Dec. 2021, pp. 6307–13. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-21-1600.

APA

Pizzamiglio, S., Ciniselli, C. M., Triulzi, T., Gargiuli, C., De Cecco, L., de Azambuja, E., Fumagalli, D., Sotiriou, C., Harbeck, N., Izquierdo, M., Nuciforo, P., Huober, J., Cappelletti, V., Cinieri, S., Piccart, M., Daidone, M. G., Pruneri, G., Colombo, M. P., Tagliabue, E., … Di Cosimo, S. (2021). Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(23), 6307–6313. https://doi.org/10.1158/1078-0432.CCR-21-1600

Chicago

Pizzamiglio, Sara, Chiara Maura Ciniselli, Tiziana Triulzi, Chiara Gargiuli, Loris De Cecco, Evandro de Azambuja, Debora Fumagalli, et al. 2021. “Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27 (23): 6307–13. doi:10.1158/1078-0432.CCR-21-1600.